Issued Patents All Time
Showing 1–14 of 14 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11884624 | Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions | Stephen Douglas Barrett, Fred Lawrence Ciske, Joseph Michael Colombo, Gregory William Endres, Bradlee David Germain +3 more | 2024-01-30 |
| 11345690 | Methods of synthesizing a difluorolactam analog | Stephen Douglas Barrett, Joseph Michael Colombo, Bradlee David Germain, Andriy Kornilov, James Bernard Kramer | 2022-05-31 |
| 11066361 | Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions | Stephen Douglas Barrett, Fred Lawrence Ciske, Joseph Michael Colombo, Gregory William Endres, Bradlee David Germain +3 more | 2021-07-20 |
| 10729810 | Methods, systems, and compositions for promoting bone growth | Stephen Douglas Barrett, Joseph Michael Colombo, Bradlee David Germain, Andriy Kornilov, James Bernard Kramer +4 more | 2020-08-04 |
| 10556862 | Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions | Stephen Douglas Barrett, Fred Lawrence Ciske, Joseph Michael Colombo, Gregory William Endres, Bradlee David Germain +3 more | 2020-02-11 |
| 9914725 | Methods of synthesizing a difluorolactam analog | Stephen Douglas Barrett, Joseph Michael Colombo, Bradlee David Germain, Andriy Kornilov, James Bernard Kramer | 2018-03-13 |
| 9701630 | Difluorolactam compositions for EP4-mediated osteo related diseases and conditions | Stephen Douglas Barrett, Fred Lawrence Ciske, Joseph Michael Colombo, Gregory William Endres, Bradlee David Germain +4 more | 2017-07-11 |
| 9688627 | Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions | Stephen Douglas Barrett, Joseph Michael Colombo, Bradlee David Germain, Gregory William Endres, Andriy Komilov +5 more | 2017-06-27 |
| 9676712 | Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions | Stephen Douglas Barrett, Bradlee David Germain, Fred Lawrence Ciske, Gregory William Endres, Andriy Kornilov +3 more | 2017-06-13 |
| 9487478 | Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions | Stephen Douglas Barrett, Fred Lawrence Ciske, Joseph Michael Colombo, Gregory William Endres, Bradlee David Germain +3 more | 2016-11-08 |
| 9440919 | Difluorolactam compositions for EP4-mediated osteo related diseases and conditions | Stephen Douglas Barrett, Fred Lawrence Ciske, Joseph Michael Colombo, Gregory William Endres, Bradlee David Germain +4 more | 2016-09-13 |
| 9180116 | Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions | Stephen Douglas Barrett, Fred Lawrence Ciske, Joseph Michael Colombo, Gregory William Endres, Bradlee David Germain +3 more | 2015-11-10 |
| 8680327 | Methods for manufacturing tetranor-prostaglandin D, J, E, A and F metabolites | Gregory William Endres, Andriy Kornilov | 2014-03-25 |
| 8063240 | Prostaglandin E1 and E2 analogs for the treatment of various medical conditions | Nancy Barta, Stephen Douglas Barrett, Gregory William Endres, Andriy Kornilov, Kirk M. Maxey | 2011-11-22 |